Literature DB >> 8570530

Drug delivery studies in Caco-2 monolayers. IV. Absorption enhancer effects of cyclodextrins.

L Hovgaard1, H Brøndsted.   

Abstract

PURPOSE: The purpose of the present study was to use the human colorectal carcinoma cell line. Caco-2, as a human intestinal epithelial model for studying the effects of cyclodextrins as absorption enhancers.
METHODS: Cyclodextrins of varying sizes and physicochemical characters were investigated. The effects of the cyclodextrins were evaluated by means of staining of the cytoplasma and determination of the mitochondrial dehydrogenase activity as well as by transport enhancement of the macromolecular pore marker polyethylene glycol 4000 (PEG-4000) across the Caco-2 monolayers.
RESULTS: The transport enhancing properties of the cyclodextrins were found to follow the lipophilicity of the core in their cyclic structure. Dimethyl-beta-cyclodextrin was the most powerful in all aspects and caused an increase in the permeability of the cytoplasma membrane in a concentration dependent manner. It was possible to increase the overall transport of PEG-4000 10-fold by the use of dimethyl-beta-cyclodextrin in low concentrations where the toxic effects on the monolayers were insignificant. It was further observed that the basolateral membrane was significantly more sensitive to cyclodextrins than the apical membrane.
CONCLUSIONS: Since dimethyl-beta-cyclodextrin was able to produce an absorption enhancing effect on PEG-4000 in concentrations where the toxic effects on Caco-2 monolayers were low it is worth to pursue the compound as an absorption enhancer.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8570530     DOI: 10.1023/a:1016225707807

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  9 in total

1.  Absorption of recombinant human granulocyte colony-stimulating factor (rhG-CSF) and blood leukocyte dynamics following intranasal administration in rabbits.

Authors:  Y Watanabe; Y Matsumoto; M Yamaguchi; R Kikuchi; K Takayama; H Nomura; K Maruyama; M Matsumoto
Journal:  Biol Pharm Bull       Date:  1993-01       Impact factor: 2.233

2.  Nasal insulin delivery with dimethyl-beta-cyclodextrin as an absorption enhancer in rabbits: powder more effective than liquid formulations.

Authors:  N G Schipper; S G Romeijn; J C Verhoef; F W Merkus
Journal:  Pharm Res       Date:  1993-05       Impact factor: 4.200

3.  Safety of oral cyclodextrins: effects of hydroxypropyl cyclodextrins, cyclodextrin sulfates and cationic cyclodextrins on steroid balance in rats.

Authors:  A Gerloczy; T Hoshino; J Pitha
Journal:  J Pharm Sci       Date:  1994-02       Impact factor: 3.534

4.  Epithelial transport of drugs in cell culture. VIII: Effects of sodium dodecyl sulfate on cell membrane and tight junction permeability in human intestinal epithelial (Caco-2) cells.

Authors:  E K Anderberg; P Artursson
Journal:  J Pharm Sci       Date:  1993-04       Impact factor: 3.534

5.  Cyclodextrins as mucosal absorption promoters of insulin. II. Effects of beta-cyclodextrin derivatives on alpha-chymotryptic degradation and enteral absorption of insulin in rats.

Authors:  Z Shao; Y Li; T Chermak; A K Mitra
Journal:  Pharm Res       Date:  1994-08       Impact factor: 4.200

6.  Cyclodextrins as nasal absorption promoters of insulin: mechanistic evaluations.

Authors:  Z Shao; R Krishnamoorthy; A K Mitra
Journal:  Pharm Res       Date:  1992-09       Impact factor: 4.200

7.  Absorption enhancement of polypeptide drugs by cyclodextrins. I. Enhanced rectal absorption of insulin from hollow-type suppositories containing insulin and cyclodextrins in rabbits.

Authors:  Y Watanabe; Y Matsumoto; M Seki; M Takase; M Matsumoto
Journal:  Chem Pharm Bull (Tokyo)       Date:  1992-11       Impact factor: 1.645

8.  Enhancing effect of cyclodextrins on nasal absorption of insulin and its duration in rabbits.

Authors:  Y Watanabe; Y Matsumoto; K Kawamoto; S Yazawa; M Matsumoto
Journal:  Chem Pharm Bull (Tokyo)       Date:  1992-11       Impact factor: 1.645

Review 9.  Medicinal applications of cyclodextrins.

Authors:  J Szejtli
Journal:  Med Res Rev       Date:  1994-05       Impact factor: 12.944

  9 in total
  9 in total

Review 1.  Modeling kinetics of subcellular disposition of chemicals.

Authors:  Stefan Balaz
Journal:  Chem Rev       Date:  2009-05       Impact factor: 60.622

2.  Prediction of dissolution-absorption relationships from a continuous dissolution/Caco-2 system.

Authors:  M J Ginski; R Taneja; J E Polli
Journal:  AAPS PharmSci       Date:  1999

3.  A novel oral preparation of hydroxysafflor yellow A base on a chitosan complex: a strategy to enhance the oral bioavailability.

Authors:  Guan-nan Ma; Fang-lin Yu; Shan Wang; Zhi-ping Li; Xiang-yang Xie; Xing-guo Mei
Journal:  AAPS PharmSciTech       Date:  2014-12-16       Impact factor: 3.246

4.  Effect of cyclodextrins on the complexation and nasal permeation of melatonin.

Authors:  R Jayachandra Babu; Pankaj Dayal; Mandip Singh
Journal:  Drug Deliv       Date:  2008-08       Impact factor: 6.419

5.  Beta cyclodextrins enhance adenoviral-mediated gene delivery to the intestine.

Authors:  M A Croyle; B J Roessler; C P Hsu; R Sun; G L Amidon
Journal:  Pharm Res       Date:  1998-09       Impact factor: 4.200

6.  Cyclodextrins in nasal delivery of low-molecular-weight heparins: in vivo and in vitro studies.

Authors:  Tianzhi Yang; Alamdar Hussain; Jennifer Paulson; Thomas J Abbruscato; Fakhrul Ahsan
Journal:  Pharm Res       Date:  2004-07       Impact factor: 4.200

7.  Effects of alpha-cyclodextrin on water transport, cell hydration and longevity.

Authors:  Lajos Szente; István Puskás; Tibor Vellai; Horst Lohmann
Journal:  Aging (Albany NY)       Date:  2021-01-19       Impact factor: 5.682

8.  Antiproliferative effect of methyl-beta-cyclodextrin in vitro and in human tumour xenografted athymic nude mice.

Authors:  P Y Grosse; F Bressolle; F Pinguet
Journal:  Br J Cancer       Date:  1998-11       Impact factor: 7.640

9.  Cholesterol depletion by methyl-β-cyclodextrin augments tamoxifen induced cell death by enhancing its uptake in melanoma.

Authors:  Naoshad Mohammad; Parmanand Malvi; Avtar Singh Meena; Shivendra Vikram Singh; Balkrishna Chaube; Garikapati Vannuruswamy; Mahesh J Kulkarni; Manoj Kumar Bhat
Journal:  Mol Cancer       Date:  2014-09-01       Impact factor: 27.401

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.